At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the University of Cambridge, Cambridge, United Kingdom, provides an overview of the opportunities and challenges associated with applying the knowledge of a patient’s genetic susceptibility for breast cancer in clinical management, including the potential to individualise breast cancer screening options and risk-reduction measures.
Allergy & Immunology
